Trials / Recruiting
RecruitingNCT07414329
Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
Evaluation of Efficacy and Effectiveness of the Investigational Sonova Behind-the-Ear Rechargeable Hearing Device Kit 2 - 2025
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Sonova AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if Sonova's rechargeable behind-the-ear hearing device kit works to treat hearing loss in adults. The main questions it aims to answer are: * Does the rechargeable behind-the-ear hearing device kit address challenging listening situations identified by participants while providing a satisfactory user experience? * Does the rechargeable behind-the-ear hearing device kit improve speech understanding in noise in a lab setting? Researchers will compare participants' performance with the rechargeable behind-the-ear hearing device kit to the unaided condition to see if it works to treat hearing loss. The rechargeable behind-the-ear hearing device kit will be subjectively compared to their personal hearing device experience. Participants will: * Use the rechargeable behind-the-ear hearing device kit for approximately 2 weeks. * Visit the clinic for the initial fitting and follow-up testing at the end of the study. Additional study visits may take place, as needed. * Complete questionnaires to identify challenging listening situations and provide feedback on their experience with the devices. * Complete lab testing to assess speech intelligibility in the presence of background noise and provide subjective feedback on features in the Mobile application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rechargeable behind-the-ear hearing device kit | This intervention includes the following components: hearing aid, charger, applicable accessories |
Timeline
- Start date
- 2026-01-30
- Primary completion
- 2026-03-31
- Completion
- 2026-04-15
- First posted
- 2026-02-17
- Last updated
- 2026-02-17
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT07414329. Inclusion in this directory is not an endorsement.